AmyPro: a database of proteins with validated amyloidogenic regions

Abstract Soluble functional proteins may transform into insoluble amyloid fibrils that deposit in a variety of tissues. Amyloid formation is a hallmark of age-related degenerative disorders. Perhaps surprisingly, amyloid fibrils can also be beneficial and are frequently exploited for diverse functional roles in organisms. Here we introduce AmyPro, an open-access database providing a comprehensive, carefully curated collection of validated amyloid fibril-forming proteins from all kingdoms of life classified into broad functional categories (http://amypro.net). In particular, AmyPro provides the boundaries of experimentally validated amyloidogenic sequence regions, short descriptions of the functional relevance of the proteins and their amyloid state, a list of the experimental techniques applied to study the amyloid state, important structural/functional/variation/mutation data transferred from UniProt, a list of relevant PDB structures categorized according to protein states, database cross-references and literature references. AmyPro greatly improves on similar currently available resources by incorporating both prions and functional amyloids in addition to pathogenic amyloids, and allows users to screen their sequences against the entire collection of validated amyloidogenic sequence fragments. By enabling further elucidation of the sequential determinants of amyloid fibril formation, we hope AmyPro will enhance the development of new methods for the precise prediction of amyloidogenic regions within proteins.

[1]  Antony Le Béchec,et al.  AMYPdb: A database dedicated to amyloid precursor proteins , 2008, BMC Bioinformatics.

[2]  Maria Jesus Martin,et al.  ProtVista: visualization of protein sequence annotations , 2017, Bioinform..

[3]  David Eisenberg,et al.  Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.

[4]  Michele Vendruscolo,et al.  Proteome-level interplay between folding and aggregation propensities of proteins. , 2010, Journal of molecular biology.

[5]  Stavros J Hamodrakas,et al.  The pentapeptide LQVVR plays a pivotal role in human cystatin C fibrillization , 2015, FEBS letters.

[6]  Priyanka Bhat,et al.  Antimicrobial peptide (Cn‐AMP2) from liquid endosperm of Cocos nucifera forms amyloid‐like fibrillar structure , 2016, Journal of peptide science : an official publication of the European Peptide Society.

[7]  David Eisenberg,et al.  In Brief , 2009, Nature Reviews Neuroscience.

[8]  Giampaolo Merlini,et al.  Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines , 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[9]  Agueda Rostagno,et al.  A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.

[10]  Robert A. Grothe,et al.  Structure of the cross-beta spine of amyloid-like fibrils. , 2005, Nature.

[11]  Andreas Hoenger,et al.  Identification of a novel ‘aggregation‐prone’/‘amyloidogenic determinant’ peptide in the sequence of the highly amyloidogenic human calcitonin , 2013, FEBS letters.

[12]  Gunna Christiansen,et al.  Fibril Core of Transforming Growth Factor Beta-Induced Protein (TGFBIp) Facilitates Aggregation of Corneal TGFBIp. , 2015, Biochemistry.

[13]  Atanas V Koulov,et al.  Functional amyloid--from bacteria to humans. , 2007, Trends in biochemical sciences.

[14]  A. Mary Thangakani,et al.  CPAD, Curated Protein Aggregation Database: A Repository of Manually Curated Experimental Data on Protein and Peptide Aggregation , 2016, PloS one.

[15]  Abhik Mukhopadhyay,et al.  PDBe: improved accessibility of macromolecular structure data from PDB and EMDB , 2015, Nucleic Acids Res..

[16]  Justin Legleiter,et al.  The role of amyloidogenic protein oligomerization in neurodegenerative disease , 2013, Journal of Molecular Medicine.

[17]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[18]  P. Martino,et al.  Identification of an amyloidogenic peptide from the Bap protein of Staphylococcus epidermidis. , 2013, Protein and peptide letters.

[19]  Guido Franceschini,et al.  Structure, function and amyloidogenic propensity of apolipoprotein A-I , 2006, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[20]  T Bek,et al.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Joost J. J. van Durme,et al.  WALTZ-DB: a benchmark database of amyloidogenic hexapeptides , 2015, Bioinform..

[22]  Claudio Soto,et al.  Amyloid Formation Modulates the Biological Activity of a Bacterial Protein* , 2005, Journal of Biological Chemistry.

[23]  M. Chapman,et al.  Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis , 2009, Proceedings of the National Academy of Sciences.

[24]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[25]  Malgorzata Kotulska,et al.  AmyLoad: website dedicated to amyloidogenic protein fragments , 2015, Bioinform..

[26]  Baltazar Becerril,et al.  A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis. , 2010, Journal of molecular biology.

[27]  L. Serrano,et al.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. , 2004, Journal of molecular biology.

[28]  Stavros J. Hamodrakas,et al.  A Consensus Method for the Prediction of ‘Aggregation-Prone’ Peptides in Globular Proteins , 2013, PloS one.

[29]  C. Dobson,et al.  The amyloid state and its association with protein misfolding diseases , 2014, Nature Reviews Molecular Cell Biology.

[30]  G. Howlett,et al.  Identification of an amyloid fibril forming peptide comprising residues 46–59 of apolipoprotein A‐I , 2012, FEBS letters.

[31]  Nikolaos N. Louros,et al.  Structural studies of “aggregation‐prone” peptide‐analogues of teleostean egg chorion ZPB proteins , 2014, Biopolymers.

[32]  Stavros J Hamodrakas,et al.  Exploring the 'aggregation-prone' core of human Cystatin C: A structural study. , 2015, Journal of structural biology.

[33]  Weigang Qiu,et al.  Candida albicans Als Adhesins Have Conserved Amyloid-Forming Sequences , 2007, Eukaryotic Cell.

[34]  María Martín,et al.  UniProt: A hub for protein information , 2015 .

[35]  Stavros J. Hamodrakas,et al.  Structural Analysis of Peptide-Analogues of Human Zona Pellucida ZP1 Protein with Amyloidogenic Properties: Insights into Mammalian Zona Pellucida Formation , 2013, PloS one.

[36]  Claudio Soto,et al.  Type 2 diabetes as a protein misfolding disease. , 2015, Trends in molecular medicine.

[37]  R. Losick,et al.  Amyloid fibers provide structural integrity to Bacillus subtilis biofilms , 2010, Proceedings of the National Academy of Sciences.

[38]  Duilio Cascio,et al.  Uncovering the Mechanism of Aggregation of Human Transthyretin , 2015, The Journal of Biological Chemistry.

[39]  M. Sunde,et al.  Functional amyloid: widespread in Nature, diverse in purpose. , 2014, Essays in biochemistry.